blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2125848

EP2125848 - ANTIVIRAL COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.07.2015
Database last updated on 30.10.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BG, HU, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
THERAPICON SRL
Via Malachia Marchesi de Taddei 21
20146 Milan / IT
[2014/37]
Former [2009/49]For all designated states
THERAPICON SRL
Via Malachia Marchesi de Taddei 21
20146 Milan / IT
Inventor(s)01 / VERONESI, Paolo Alberto
Via Malachia Marchesi De Taddei 21
I-20146 Milan / IT
02 / RODRIGUEZ, Pablo Eduardo Andres
Libertad 1710
Barrio General Paz
Cordoba, 5000 / AR
03 / PESCHECHERA, Emanuela
Via Malachia Marchesi de Taddei 21
I-20146 Milan / IT
04 / VERONESI, Susanna Lucia
Via Malachia Marchesi de Taddei 21
I-20146 Milan / IT
 [2014/37]
Former [2009/49]01 / VERONESI, Paolo Alberto
Via Malachia Marchesi De Taddei 21
I-20146 Milan / IT
02 / RODRIGUEZ, Pablo Eduardo Andres
Libertad 1710 Barrio General Paz
Cordoba, 5000 / AR
03 / PESCHECHERA, Emanuela
Via Malachia Marchesi de Taddei 21
I-20146 Milan / IT
04 / VERONESI, Susanna Lucia
Via Malachia Marchesi de Taddei 21
I-20146 Milan / IT
Representative(s)Colombo, Stefano Paolo, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
[N/P]
Former [2013/11]Colombo, Stefano Paolo, et al
MARCHI & PARTNERS S.r.l. Via G.B. Pirelli, 19
20124 Milano / IT
Former [2010/51]Murphy, Colm Damien, et al
Ipulse 26 Mallinson Road London
SW11 1BP / GB
Former [2009/49]Murphy, Colm Damien
Ipulse 26 Mallinson Road London
SW11 1BP / GB
Application number, filing date08708068.522.01.2008
[2009/49]
WO2008EP50703
Priority number, dateIT2007MI0009323.01.2007         Original published format: IT MI20070093
IT2007MI0221222.11.2007         Original published format: IT MI20072212
[2009/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008090151
Date:31.07.2008
Language:EN
[2008/31]
Type: A1 Application with search report 
No.:EP2125848
Date:02.12.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2008 takes the place of the publication of the European patent application.
[2009/49]
Type: B1 Patent specification 
No.:EP2125848
Date:10.09.2014
Language:EN
[2014/37]
Search report(s)International search report - published on:EP31.07.2008
ClassificationIPC:C07H7/00, C07H19/056, C07D309/14, A61K31/7012, A61P31/12
[2009/49]
CPC:
C07H7/00 (EP,US); C07H19/056 (EP,KR,US); A61K31/7012 (KR);
A61P31/12 (EP); A61P31/14 (EP); A61P31/16 (EP);
C07D309/14 (EP,KR,US); C07D405/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/49]
TitleGerman:ANTIVIRALE VERBINDUNGEN[2009/49]
English:ANTIVIRAL COMPOUNDS[2009/49]
French:COMPOSÉS ANTIVIRAUX[2009/49]
Entry into regional phase11.06.2009National basic fee paid 
11.06.2009Designation fee(s) paid 
11.06.2009Examination fee paid 
Examination procedure11.06.2009Amendment by applicant (claims and/or description)
11.06.2009Examination requested  [2009/49]
08.03.2011Despatch of a communication from the examining division (Time limit: M04)
30.06.2011Reply to a communication from the examining division
27.09.2011Despatch of a communication from the examining division (Time limit: M04)
27.01.2012Reply to a communication from the examining division
28.10.2013Communication of intention to grant the patent
26.02.2014Fee for grant paid
26.02.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.03.2011
Opposition(s)11.06.2015No opposition filed within time limit [2015/34]
Fees paidRenewal fee
29.01.2010Renewal fee patent year 03
25.01.2011Renewal fee patent year 04
25.01.2012Renewal fee patent year 05
25.01.2013Renewal fee patent year 06
29.07.2014Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.01.201407   M06   Fee paid on   29.07.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU22.01.2008
AT10.09.2014
BE10.09.2014
BG10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
MT10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
TR10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
IE22.01.2015
LU22.01.2015
[2017/39]
Former [2017/03]AT10.09.2014
BE10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
MT10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
IE22.01.2015
LU22.01.2015
Former [2016/32]AT10.09.2014
BE10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
IE22.01.2015
LU22.01.2015
Former [2016/07]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
IE22.01.2015
LU22.01.2015
BE31.01.2015
Former [2015/50]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SI10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
LU22.01.2015
BE31.01.2015
Former [2015/43]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
MC10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
LU22.01.2015
BE31.01.2015
Former [2015/39]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
LU22.01.2015
BE31.01.2015
Former [2015/34]AT10.09.2014
CY10.09.2014
CZ10.09.2014
DK10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
BE31.01.2015
Former [2015/30]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
BE31.01.2015
Former [2015/25]AT10.09.2014
CY10.09.2014
CZ10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/24]CY10.09.2014
CZ10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
PL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/23]CY10.09.2014
CZ10.09.2014
EE10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
RO10.09.2014
SE10.09.2014
SK10.09.2014
NO10.12.2014
GR11.12.2014
IS10.01.2015
PT12.01.2015
Former [2015/22]CY10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
RO10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
PT12.01.2015
Former [2015/16]CY10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
NL10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/12]CY10.09.2014
ES10.09.2014
FI10.09.2014
HR10.09.2014
LT10.09.2014
LV10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/11]CY10.09.2014
ES10.09.2014
FI10.09.2014
LT10.09.2014
SE10.09.2014
NO10.12.2014
GR11.12.2014
Former [2015/10]ES10.09.2014
FI10.09.2014
LT10.09.2014
SE10.09.2014
NO10.12.2014
Former [2015/09]FI10.09.2014
LT10.09.2014
SE10.09.2014
Former [2015/08]LT10.09.2014
Cited inInternational search[XD]WO9206691  (BIOTA SCIENT MANAGEMENT [AU]) [XD] 1 * X for R4 is -CHOH-CHOH-CH2-OH *;
 [X]WO0029419  (TROPIX INC [US]) [X] 1 * X for R4 is -CHOH-CHOH-CH2-OH *
 [XDA]  - ITZSTEIN VON M ET AL, "RATIOANL DESIGN OF POTENT SIALIDASE-BASED INHIBITORS OF INFLUENZA VIRUS REPLICATION", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (19930603), vol. 363, ISSN 0028-0836, pages 418 - 423, XP000574955 [XD] 1 * the whole document * [A] 8

DOI:   http://dx.doi.org/10.1038/363418a0
 [XD]  - SUDHAKAR BABU Y ET AL, "BCX-1812 (RWJ-270201): DISCOVERY OF A NOVEL, HIGHLY POTENT, ORALLY ACTIVE, AND SELECTIVE INFLUENZA NEURAMINIDASE INHIBITOR THROUGH STRUCTURE-BASED DRUG DESIGN", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (2000), vol. 43, no. 19, ISSN 0022-2623, pages 3482 - 3486, XP009049012 [XD] 1 * X for R4 is -CHOH-CHOH-CH2-OH *

DOI:   http://dx.doi.org/10.1021/jm0002679
by applicantWO9206691
 EP0539204
 WO9116320
 US5952375
 WO9933781
    - YOSHINORI FUJIYOSHI ET AL., "Fine structure if influenza A virus observed by electron cryo-microscopy", THE EMBO JOURNAL, (1994), vol. 13, no. 2, pages 318 - 326
    - WILSON I. A. ET AL., "Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 A resolution", NATURE, (1981), vol. 289, doi:doi:10.1038/289366a0, pages 366 - 373, XP002689324

DOI:   http://dx.doi.org/10.1038/289366a0
    - VARGHESE J. N. ET AL., "Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution", NATURE, (1983), vol. 303, pages 35 - 40
    - COLMAN P. M. ET AL., "Structure of the catalytic and antigenic sites in influenza virus neuraminidase", NATURE, (1983), vol. 303, pages 41 - 44
    - HERRIER GEORG ET AL., "A synthetic sialic acid analogue is recognized by influenza C virus as a receptor but is resistant to the receptor-destroying enzyme", J. BIOL. CHEM., (1992), vol. 2567, no. 8, pages 12501 - 12505
    - ITZSTEIN, M. VON ET AL., NATURE, (1993), vol. 363, no. 6428, pages 418 - 423
    - BABU Y.S.; CHAD P.; BANTIA S. ET AL., "Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design", J MED CHEM, (2000), vol. 43, no. 19, doi:doi:10.1021/jm0002679, page 3482, XP009049012

DOI:   http://dx.doi.org/10.1021/jm0002679
    - Martindale 33.rd Ed., (2002), pages 639 - 643
    - TANG ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1985), vol. 132, pages 474 - 480
    - STOLL ET AL., BIOCHEM. J., (1988), vol. 256, pages 661 - 664
    - SCHARZMANN G. ET AL., BIOCHEM., (1983), vol. 22, pages 5041 - 5049
    - IAN T; HARRISON; SHUYE, HARRISON, Compendium of Organic Synthetic Methods, JOHN WILEY & SONS, (1971), vol. 1
    - IAN T. HARRISON; SHUYEN HARRISON, COMPENDIUM OF ORGANIC SYNTHETIC METHODS, (1974), vol. 2
    - LOUIS S. HEGEDUS; LEROY WADE, COMPENDIUM OF ORGANIC SYNTHETIC METHODS, (1977), vol. 3
    - LEROY G.; WADE, JR., COMPENDIUM OF ORGANIC SYNTHETIC METHODS, (1980), vol. 4
    - LEROY G. WADE, JR., COMPENDIUM OF ORGANIC SYNTHETIC METHODS, (1984), vol. 5
    - MICHAEL B. SMITH, COMPENDIUM OF ORGANIC SYNTHETIC METHODS, vol. 6
    - Comprehensive Organic Synthesis. Selectivity, Strategy & Efficacy in modern Organic Chemistry, PERGAMON PRESS, NEW YORK, (1993), vol. 9
    - SVENNERHOLM L., "Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.", BIOCHEM. BIOPHYS. ACTA, (1957), vol. 24, no. 3, doi:doi:10.1016/0006-3002(57)90254-8, pages 604 - 611, XP009050496

DOI:   http://dx.doi.org/10.1016/0006-3002(57)90254-8
    - MIETTINEN J. ET AL., "Use of butyl acetate in determination of sialic acid.", ACTA CHEM. SCAND., (1959), vol. 13, pages 856 - 858
    - WARREN L., "The thiobarbituric acid assay of sialic acids.", J. BIOL. CHEM., (1959), vol. 234, pages 1971 - 1975, XP055203432

DOI:   http://dx.doi.org/10.1016/0076-6879(63)06207-8
    - AMINOFF D., "Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids.", BIOCHEM. J., (1961), vol. 81, no. 2, pages 384 - 392
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING CO.
 WO2008AU00501
 EP19920309684
 WO2008AU00161
 US19960606624
 WO1998US26871
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.